Abstract
Recently we reported ‘myogenic hyperuricemia’ in muscle glycogenosis types III, V and VII (Kono et al., 1986; Kono et al., 1987; Mineo et al., 1985; Mineo et al., 1987). The mechanism of myogenic hyperuricemia is: when energy production does not fill its requirement for continuing exercise, purine nucleotide degradation is accelerated (Fig. 1). The degradation of purine nucletide occurs even with mild exercise in these diseases. Its degradative metabolites such as inosine, hypoxanthine, and ammonia are released from working muscles into blood stream. Inosine and hypoxanthine are taken up by liver and metabolized to uric acid, causing hyperuricemia. In this study, we report exercise-induced alteration of erythrocyte glycolysis in muscle glycogenoses(Fig. 1), which is another metabolic consequence caused by accelerated purine nucleotide degradation in muscle.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cade, R., Conte, M., Zauner, C., Mars, D., Peterson, J., Lunne, D., Hommen, N., and Packer, D., 1984, Effects of phosphate loading on 2, 3-diphosphoglycerate and maximal oxygen uptake, Med. Sci. Sports. Exerc. 16: 263
Grimes, A. J., 1980, Normal and abnormal enzymes of the Embden-Meyerhof pathway (excluding pyruvate kinase), in: “Human Red Cell Metabolism”, Blackwell, Edinburgh, p 108
Grimes, A. J., 1980, Some acquired defects of red cells, in: “Human Red Cell Metabolism”, Blackwell, Edinburgh, p 276
Hoyt, R. W., Wood, S. C., Hicks, J. W., and Asakura, T., 1983, Effect of long distance running at high altitude on the standard oxyhemoglobin dissociation curve and red cell 2, 3-DPG, Eur. J. Appl. Physiol. 51: 175
Kono, N., Kuwajima, M., and Tarui, S., 1981, Alteration of glycolytic intermediary metabolism in erythrocytes during diabetic ketoacidosis and its recovery phase, Diabetes 30: 346
Kono, N., Mineo, I., Shimizu, T., Hara, N., Yamada, Y., Nonaka, K., and Tarui, S., 1986, Increased plasma uric acid after exercise in muscle phosphofructokinase deficiency, Neurology 36: 106
Kono, N., Mineo, I., and Tarui, S., 1987, Hyperuricemia in type V glycogenosis, Neurology (NY) 37: 278
Mairbaurl, H., Humpeler, E., Schwaberger, G., and Pessenhofer, H., 1983, Training-dependent changes of red cell density and erythrocyte oxygen transport, J. Appl. Physiol. 55: 1403
Mairbaurl, H., Schobersberger, W., Hasibeder, W., Schwaberger, G., Gaesser, G., and Tanaka, K. R., 1986, Regulation of red cell 2, 3-DPG and HbO2-affinity during acute exercise, Eur. J. Appl. Physiol. 55: 174
Meen, H.D., Holter, P.H., and Refsum, H.E., 1981, Changes in 2, 3-diphosphoglycerate (2, 3-DPG) after exercise, Eur. J. Appl. Physiol. 46: 177
Mineo, I., Kono, N., Shimizu, T., Sumi, S., Nonaka, K., and Tarui, S., 1984, A comparative study on glucagon effect between McArdle disease and Tarui disease, Muscle Nerve 7: 552
Mineo, I., Kono, N., Shimizu, T., Hara, N., Yamada, Y., Sumi, S., Nonaka, K., and Tarui, S., 1985, Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII, J. Clin. Invest. 76: 556.
Mineo, I., Kono, N., Hara, N., Shimizu, T., Yamada, Y., Kawachi, M., Kiyokawa, H., Wang, Y. L., and Tarui, S., 1987, Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V and VII, N. Engl. J. Med. 317: 75
Ramsey, J.M., and Pipoly, S. W. Jr, 1979, Response to erythrocyte 2, 3-diphosphoglycerate to strenous exercise, Eur J Appl Physiol 40: 227
Remes, K., Harkonen, M., Vuipio, P., and Peltokallio, P., 1975, The decrease in 2, 3-diphosphoglyecerate concentration in long distance running, J. Sports. Med. 15: 113
Ricci, G., Castaldi, G., Masotti, M., Lupi G., and Bonetti, D., 1984, 2, 3-diphosphoglycerate and P50 after exercise, Acta. Haematol. (Basel) 71: 410
Shappell, S. D., Murray, J. A., Bellingham, A. J., Woodson, R. D., Detter, F. C., and Lenfant, C., 1971, Adaptation to exercise: Role of hemoglobin affinity for oxygen and 2, 3-diphosphoglycerate, J. Appl. Physiol. 30: 827
Tarui, S., Okuno, G., Ikura, Y., Tanaka, T., Suda, M., and Nishikawa, M., 1965, phosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis, Biochem. Biophys. Res. Commun. 19: 517
Tarui, S., Kono, N., Nasu, T., and Nishikawa, M., 1969, Enzymatic basis for the coexistence of myopathy and hemolytic disease in inherited muscle phosphofructokinase deficiency, Biochem. Biophys. Res. Commun. 34: 77
Tauton, J. E., Tauton, C. A., and Banister, E. W., 1974, Alterations in 2, 3-dpg and P50 with maximal and submaximal exercise, Med. Sci. Sports. Exerc. 6: 238
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Shimizu, T. et al. (1989). Exercise Induced Alteration of Erythrocyte Glycolysis Associated with Myogenic Hyperuricemia. In: Mikanagi, K., Nishioka, K., Kelley, W.N. (eds) Purine and Pyrimidine Metabolism in Man VI. Advances in Experimental Medicine and Biology, vol 253A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5673-8_61
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5673-8_61
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5675-2
Online ISBN: 978-1-4684-5673-8
eBook Packages: Springer Book Archive